EMA Alters Guidance on Clinical Trials Data Submission Requirements

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency made several changes to a guidance explaining the agency’s policy for publishing clinical trials data and factors that could lead to rejection.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor